Showing 16,581 - 16,600 results of 43,924 for search '(( 5 ((teer decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 16581
  2. 16582
  3. 16583
  4. 16584
  5. 16585
  6. 16586

    AKT regulates UGCG expression via epigenomic alterations. by Mohammad Nafees Ansari (22232505)

    Published 2025
    “…(<b>H</b>) ChIP-qPCR results (mean ± SEM, <i>n</i> = 3) confirm enhanced binding of ZFX to UGCG promoter in MCF-7_RICTOR<sup>SH</sup> cells on DAC (5 μM) treatment. …”
  7. 16587
  8. 16588
  9. 16589
  10. 16590
  11. 16591
  12. 16592
  13. 16593
  14. 16594
  15. 16595
  16. 16596

    A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer by Shu-Fu Lin (126854)

    Published 2017
    “…<div><p>Background</p><p>We explored the therapeutic effects of dinaciclib, a cyclin-dependent kinase (CDK) inhibitor, in the treatment of thyroid cancer.…”
  17. 16597

    Table_1_Central Multifocal Choroiditis: Platelet Granularity as a Potential Marker for Treatment With Steroid-Sparing Immunomodulatory Therapy.docx by Evianne L. de Groot (11937257)

    Published 2022
    “…</p>Results<p>At a false discovery rate of 5% (P<sub>adj</sub>), we identified a decrease of blood monocytes in cases with cMFC, which could be attributed to disease activity. …”
  18. 16598
  19. 16599

    A coarse-grained sensitivity analysis of the effect of drug-induced resistance on treatment outcome. by Erin Angelini (13149930)

    Published 2022
    “…<p>The parameters given in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1010319#pcbi.1010319.s006" target="_blank">S1 Table</a> are held fixed, while the EC50 and efficacy of resistance induction are varied in the above four cases. …”
  20. 16600